MPLT
MapLight Therapeutics, Inc.
-0.05 (-0.44%)11.35USD96.6K成交股數482M市值0.2本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 6 · 65.5M · 2 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 45 · 11.5M · 6 |
| 其中 10b5-1 計畫賣出 | 24 筆 |
| 近 180 天 買進 · 賣出金額 | 65.5M · 27.6M |
| 近 180 天 淨額 | 37.9M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | 08-19 | Lillie James Woodruff | Chief Scientific Officer | A 獲配股票 | 7.7K | – | – | 210K | SEC |
| 2026-08-17 | 08-19 | Kroeger Christopher A. | Chief Executive Officer | A 獲配股票 | 23.1K | – | – | 1.3M | SEC |
| 2026-08-17 | 08-19 | Kreitzer Anatol | Chief Discovery Officer | A 獲配股票 | 6.0K | – | – | 181K | SEC |
| 2026-08-17 | 08-19 | Hanson Kristopher | General Counsel | A 獲配股票 | 7.7K | – | – | 154K | SEC |
| 2026-08-17 | 08-19 | GILLIS JONATHAN | CAO and Interim CFO | A 獲配股票 | 6.0K | – | – | 150K | SEC |
| 2026-08-17 | 08-19 | Foff Erin Pennock | Chief Medical Officer | A 獲配股票 | 13.4K | – | – | 312K | SEC |
| 2026-08-17 | 08-19 | GILLIS JONATHAN | CAO and Interim CFO | A 獲配股票 | 2.2K | – | – | 152K | SEC |
| 2026-08-14 | 08-18 | Catalyst4, Inc. | TenPercentOwner | P 公開市場買進 | 4.4M | 11.38 | 50.1M | 25.3M | SEC |
| 2026-08-03 | 08-04 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 22.1K | 12.54 | 277K | 202K | SEC |
| 2026-07-30 | 07-30 | Catalyst4, Inc. | TenPercentOwner | P 公開市場買進 | 1.0M | 13.00 | 13.0M | 20.9M | SEC |
| 2026-07-29 | 07-30 | Catalyst4, Inc. | TenPercentOwner | P 公開市場買進 | 3.0K | 12.63 | 38K | 19.9M | SEC |
| 2026-07-28 | 07-30 | Catalyst4, Inc. | TenPercentOwner | P 公開市場買進 | 65.1K | 11.69 | 761K | 19.9M | SEC |
| 2026-07-28 | 07-30 | Catalyst4, Inc. | TenPercentOwner | P 公開市場買進 | 141K | 10.74 | 1.5M | 19.8M | SEC |
| 2026-07-28 | 07-28 | Cox Troy | Director | P 公開市場買進 | 15.6K | 9.52 | 149K | 15.6K | SEC |
| 2026-07-17 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 17.0K | 37.61 | 638K | 145K | SEC |
| 2026-07-17 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 2.8K | 37.05 | 105K | 189K | SEC |
| 2026-07-17 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 200 | 38.39 | 8K | 175K | SEC |
| 2026-07-17 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 900 | 38.17 | 34K | 144K | SEC |
| 2026-07-17 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 600 | 36.51 | 22K | 162K | SEC |
| 2026-07-17 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 14.1K | 37.70 | 533K | 175K | SEC |
| 2026-07-17 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 1.1K | 37.90 | 43K | 146K | SEC |
| 2026-07-17 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 2.1K | 37.90 | 79K | 224K | SEC |
| 2026-07-17 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 3.7K | 37.90 | 139K | 299K | SEC |
| 2026-07-17 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 16.8K | 37.90 | 636K | 1.2M | SEC |
| 2026-07-16 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 7.5K | 36.66 | 274K | 194K | SEC |
| 2026-07-16 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 1.6K | 37.44 | 60K | 192K | SEC |
| 2026-07-16 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 1.5K | 37.44 | 55K | 163K | SEC |
| 2026-07-16 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 7.0K | 36.66 | 256K | 164K | SEC |
| 2026-07-16 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 3.3K | 37.26 | 124K | 147K | SEC |
| 2026-07-16 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.9K | 37.26 | 219K | 303K | SEC |
| 2026-07-16 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 19 | 37.96 | 721.24 | 303K | SEC |
| 2026-07-16 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 11 | 37.96 | 417.56 | 147K | SEC |
| 2026-07-16 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 4.8K | 36.45 | 174K | 150K | SEC |
| 2026-07-16 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 28.1K | 37.26 | 1.0M | 1.3M | SEC |
| 2026-07-16 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 92 | 37.96 | 3K | 1.3M | SEC |
| 2026-07-16 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.2K | 36.46 | 334K | 308K | SEC |
| 2026-07-16 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 40.9K | 36.46 | 1.5M | 1.3M | SEC |
| 2026-07-16 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 5.0K | 36.45 | 183K | 230K | SEC |
| 2026-07-16 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 12 | 37.96 | 455.52 | 227K | SEC |
| 2026-07-16 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 3.5K | 37.26 | 131K | 227K | SEC |
| 2026-07-15 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 5.4K | 36.13 | 194K | 176K | SEC |
| 2026-07-15 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 4.5K | 36.94 | 167K | 201K | SEC |
| 2026-07-15 | 07-20 | Kreitzer Anatol | Chief Discovery Officer | S 公開市場賣出(10b5-1) | 5.5K | 36.13 | 200K | 206K | SEC |
| 2026-07-15 | 07-20 | GILLIS JONATHAN | CAO and Interim CFO | S 公開市場賣出(10b5-1) | 4.7K | 36.94 | 174K | 171K | SEC |
| 2026-07-15 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 2.2K | 36.00 | 81K | 240K | SEC |
| 2026-07-15 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 5.4K | 36.99 | 199K | 235K | SEC |
| 2026-07-15 | 07-17 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出 | 12 | 37.54 | 450.48 | 235K | SEC |
| 2026-07-15 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 18 | 37.54 | 675.72 | 318K | SEC |
| 2026-07-15 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.0K | 36.99 | 332K | 318K | SEC |
| 2026-07-15 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 4.5K | 36.00 | 161K | 327K | SEC |
| 2026-07-15 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.8K | 37.04 | 291K | 331K | SEC |
| 2026-07-15 | 07-17 | Foff Erin Pennock | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.2K | 36.16 | 259K | 339K | SEC |
| 2026-07-15 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 10 | 37.54 | 375.40 | 155K | SEC |
| 2026-07-15 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 5.1K | 36.99 | 189K | 155K | SEC |
| 2026-07-15 | 07-17 | Hanson Kristopher | General Counsel | S 公開市場賣出 | 2.1K | 36.00 | 77K | 160K | SEC |
| 2026-07-15 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 90 | 37.54 | 3K | 1.3M | SEC |
| 2026-07-15 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 42.7K | 36.99 | 1.6M | 1.3M | SEC |
| 2026-07-15 | 07-17 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出 | 18.9K | 36.00 | 682K | 1.4M | SEC |
| 2026-06-23 | 06-25 | Garnett Timothy John | Director | A 獲配股票 | 3.9K | – | – | 53.5K | SEC |
| 2026-06-23 | 06-25 | Walker Maria C | Director | A 獲配股票 | 3.9K | – | – | 62.7K | SEC |
| 2026-06-23 | 06-25 | Cox Troy | Director | A 獲配股票 | 7.9K | – | – | 7.9K | SEC |
| 2026-06-23 | 06-25 | Pavlov George | Director | A 獲配股票 | 3.9K | – | – | 28.9K | SEC |
| 2026-06-23 | 06-25 | Babler Martin | Director | A 獲配股票 | 7.9K | – | – | 7.9K | SEC |
| 2026-06-23 | 06-25 | Luneborg Nanna Liebach | Director | A 獲配股票 | 3.9K | – | – | 3.9K | SEC |
| 2026-05-18 | 05-18 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 198 | 28.15 | 6K | 1.4M | SEC |
| 2026-05-18 | 05-18 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 118K | 27.19 | 3.2M | 1.4M | SEC |
| 2026-05-11 | 05-11 | Hanson Kristopher | General Counsel | S 公開市場賣出(10b5-1) | 5.8K | 30.56 | 177K | 162K | SEC |
| 2026-05-11 | 05-11 | Hanson Kristopher | General Counsel | S 公開市場賣出(10b5-1) | 846 | 28.70 | 24K | 175K | SEC |
| 2026-05-11 | 05-11 | Hanson Kristopher | General Counsel | S 公開市場賣出(10b5-1) | 284 | 27.61 | 8K | 176K | SEC |
| 2026-05-11 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 342 | 27.57 | 9K | 1.5M | SEC |
| 2026-05-11 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.9K | 30.56 | 180K | 1.5M | SEC |
| 2026-05-11 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 6.9K | 30.04 | 206K | 1.5M | SEC |
| 2026-05-11 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 877 | 28.70 | 25K | 1.5M | SEC |
| 2026-05-11 | 05-11 | Hanson Kristopher | General Counsel | S 公開市場賣出(10b5-1) | 7.0K | 30.04 | 210K | 168K | SEC |
| 2026-05-08 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 29.6K | 27.48 | 814K | 1.5M | SEC |
| 2026-05-08 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.2K | 29.20 | 94K | 1.5M | SEC |
| 2026-05-08 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.6K | 28.56 | 45K | 1.5M | SEC |
| 2026-05-07 | 05-11 | Lillie James Woodruff | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 721 | 28.28 | 20K | 243K | SEC |
| 2026-05-07 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.2K | 29.15 | 152K | 1.6M | SEC |
| 2026-05-07 | 05-11 | Kroeger Christopher A. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 14.9K | 28.47 | 424K | 1.6M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| NOVO HOLDINGS A/S | 3.7M | 132M | 新進 | 新進 |
| FCPM III SERVICES B.V. | 3.2M | 116M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.9M | 69.8M | 新進 | 新進 |
| BlackRock, Inc. | 1.0M | 36.7M | 新進 | 新進 |
| Nan Fung Group Holdings Ltd | 971K | 34.8M | 新進 | 新進 |
| 5AM Venture Management, LLC | 950K | 34.0M | 新進 | 新進 |
| Sanofi | 912K | 32.7M | 新進 | 新進 |
| STATE STREET CORP | 852K | 30.5M | 新進 | 新進 |
| FMR LLC | 824K | 29.5M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 784K | 28.1M | 新進 | 新進 |
| Blue Owl Capital Holdings LP | 730K | 26.2M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 686K | 24.6M | 新進 | 新進 |
| Pivotal bioVenture Partners Investment Advisor LLC | 611K | 21.9M | 新進 | 新進 |
| Velan Capital Investment Management LP | 493K | 17.7M | 新進 | 新進 |
| Siren, L.L.C. | 450K | 16.1M | 新進 | 新進 |
| Capital World Investors | 416K | 14.9M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 402K | 14.4M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 365K | 13.1M | 新進 | 新進 |
| DAFNA Capital Management LLC | 171K | 6.1M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 171K | 6.1M | 新進 | 新進 |
| Freestone Grove Partners LP | 169K | 6.1M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 137K | 4.9M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 129K | 4.6M | 新進 | 新進 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 125K | 4.5M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 123K | 4.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 106 +25 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 106 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 26.3M · 61.9% |
| 合計季末市值 | 789M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.4M |
|---|---|
| 與上期比 | +5.9% |
| 佔流通股數 | 8.07% |
| 日均成交量 | 601K |
| 回補天數 | 5.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.4M | +5.9% | 8.07% | 601K | 5.7 |
| 2026-08-14 | 3.2M | -9.7% | 7.63% | 590K | 5.5 |
| 2026-07-31 | 3.6M | -0.1% | 8.44% | 2.2M | 1.7 |
| 2026-07-15 | 3.6M | +39.1% | 8.45% | 534K | 6.7 |
| 2026-06-30 | 2.6M | +35.7% | 6.07% | 638K | 4.0 |
| 2026-06-15 | 1.9M | +21.6% | 4.48% | 292K | 6.5 |
| 2026-05-29 | 1.6M | +14.8% | 3.68% | 291K | 5.4 |
| 2026-05-15 | 1.4M | -22.0% | 3.21% | 243K | 5.6 |
| 2026-04-30 | 1.7M | +3.7% | 4.11% | 357K | 4.9 |
| 2026-04-15 | 1.7M | +18.6% | 3.97% | 296K | 5.7 |
| 2026-03-31 | 1.4M | +4.5% | 3.34% | 295K | 4.8 |
| 2026-03-13 | 1.4M | +0.2% | 3.20% | 143K | 9.5 |
| 2026-02-27 | 1.4M | -1.4% | 3.19% | 109K | 12.4 |
| 2026-02-13 | 1.4M | +8.1% | 3.24% | 185K | 7.4 |
| 2026-01-30 | 1.3M | +17.1% | 3.00% | 215K | 5.9 |
| 2026-01-15 | 1.1M | -43.8% | 2.56% | 178K | 6.1 |
| 2025-12-31 | 1.9M | +101.3% | 4.55% | 470K | 4.1 |
| 2025-12-15 | 959K | +25.6% | 2.26% | 328K | 2.9 |
| 2025-11-28 | 764K | +87.6% | 1.80% | 201K | 3.8 |
| 2025-11-14 | 407K | +104.8% | 0.96% | 231K | 1.8 |
| 2025-10-31 | 199K | +100.0% | 0.47% | 417K | 1.0 |